Andang, Kent .
HRN: 28-80-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2026
CEFTAZIDIME 1GM (VIAL)
04/09/2026
04/16/2026
IV
85mg
Q8hours
Neonatal Sepsis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: